# PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients

> **NCT01020604** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1376 (actual)

## Conditions studied

- Prostate Cancer
- Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01020604
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 1376 (ACTUAL)
- **Last updated:** 2013-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020604, "PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01020604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*